Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease
Discussion
Vitamin K supplementation is a simple, safe and cost-effective nutritional strategy that can easily be integrated into patient care. If vitamin K reduces the progression of coronary artery calcification it may lead to decreased morbidity and mortality in men and women with ESKD.
Trial registration
NCT 01528800.
Source: Canadian Journal of Kidney Health and Disease - Category: Urology & Nephrology Source Type: research
More News: Calcium | Cardiology | Cardiovascular | Dialysis | Health | Heart | Hemodialysis | Nutrition | Study | Urology & Nephrology | Vitamin K | Vitamin K Deficiency | Vitamins | Women